Fertility and Sterility
Volume 77 , Pages 55-59 , April 2002

Sexual effects of androgens in women: some theoretical considerations

  • John Bancroft, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: John Bancroft, M.D., Kinsey Institute, Morrison Hall 313, Indiana University, 1165 E. Third Street, Bloomington, Indiana 47405 USA (FAX: 812-855-8277
    • Kinsey Institute for Research in Sex, Gender and Reproduction, Indiana University, Bloomington, Indiana USA, USA

Received 16 October 2001 ,Revised 18 December 2001 ,Accepted 18 December 2001.

References 

  1. Carney A, Bancroft J, Mathews A. Combination of hormonal and psychological treatment for female sexual unresponsiveness (a comparative study). Br J Psychiatry. 1978;132:339–356
  2. Mathews A, Whitehead A, Kellett J. Psychological and hormonal factors in the treatment of female sexual dysfunction. Psychol Med. 1983;13:83–92
  3. Dow MGT, Gallasher J. A controlled study of combined hormonal and psychological treatment for sexual unresponsiveness in women. Br J Clin Psychol. 1989;28:201–212
  4. Bancroft J. Androgens and sexual function in men and women. In: Bremner W, Bagattel C, eds. Androgens in health and disease. Totowa: Humana Press (in press).
  5. Appelt H, Strauss B. The psychoendocrinology of female sexuality (a research project). German J Psychol. 1986;10(2):143–156
  6. Nathorst-Böös J, von Schoultz B, Carlström K. Elective ovarian removal and estrogen replacement therapy—effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol. 1993;14:283–293
  7. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM. The effects of steroidal contraceptives on the well-being and sexuality of women (a double blind, placebo-controlled, two centre study of combined and progestogen-only methods). Contraception. 1995;52:363–369
  8. Sanders SA, Graham CM, Bass J, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64:51–58
  9. Bancroft J, Herbenick D, Reynolds M. Masturbation as a marker of sexual development. In: J. Bancroft, ed. Sexual development. Bloomington: Indiana University Press (in press).
  10. Kinsey AC, Pomeroy WB, Martin CE. Sexual behavior in the human male. Philadelphia: WB Saunders; 1948;
  11. Kinsey AC, Pomeroy WB, Martin CE, Gebhard PH. Sexual behavior in the human female. Philadelphia: WB Saunders; 1953;
  12. Mor G, Eliza M, Song J, Wiita B, Chen S, Naftolin F. 17′-methyl testosterone is a competitive inhibitor of aromatase activity in JAR choriocarcinoma cells and macrophage-like THP-1 cells in culture. J Steroid Biochem Mol Biol. 2001;79:239–246
  13. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):336–343
  14. Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with oestradiol—testosterone (Clinical, lipid and hormonal results). Maturitas. 1984;6:351–358
  15. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause (a double-blind, cross-over study). Psychoneuroendocrinology. 1985;10(3):325–335
  16. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol. 1985;151(2):153–160
  17. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord. 1988;14:177–187
  18. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343(10):682–688
  19. Angst J. Sexual problems in healthy and depressed persons. International Clin Psychopharm. 1998;13(Suppl 6):S1–S4
  20. Sanders D, Warner P, Backström T, Bancroft J. Mood, sexuality, hormones and the menstrual cycle. I. Changes in mood and physical state (description of subjects and method). Psychosom Med. 1983;45:487–501
  21. Cawood EHH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psycholog Med. 1996;26:925–936
  22. Bancroft J, Loftus J, Long JS. Distress about sexuality: a national survey of women in heterosexual relationships (submitted).
  23. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality (effect of estrogen and progestogen). Obstet Gynecol. 1980;56:316–322
  24. Bancroft J, Davidson DW, Warner P, Tyrer G. Androgens and sexual behaviour in women using oral contraceptives. Clin Endocrinol. 1980;12:327–340
  25. Bancroft J, Sherwin B, Alexander GM, Davidson DW, Walker A. Oral contraceptives, androgens, and the sexuality of young women. II. The role of androgens. Arch Sex Behav. 1991;20(2):121–135
  26. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females (a prospective, crossover study of sex steroid administration in the surgical menopause). Psychosom Med. 1985;47(4):339–351
  27. Tuiten A, Laan E, Panhuysen G, Everaerd W, de Haan E, Koppeschaar H, et al.  Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom Med. 1996;58:234–241
  28. Riley A, Riley E. Controlled studies on women presenting with sexual drive disorder. I. Endocrine status. J Sex Marital Ther. 2000;26:269–283
  29. Baischer W, Koinig G, Hartmann B, Huber J, Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women (Elevated blood testosterone concentrations compared with normal controls). Psychoneuroendocrinology. 1995;20:553–559
  30. Eriksson E, Sundblad C, Lisjoe P, Modigh K, Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology. 1992;17(2–3):195–204
  31. Weber B, Lewicka S, Dueschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology. 2000;25(8):765–771
  32. Roger M, Nahoul K, Scholler R, Bagrel D. Evolution with ageing of four plasma androgens in postmenopausal women. Maturitas. 1980;2:171–177
  33. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metabol. 1995;80(4):1429–1430
  34. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril. 1996;65:721–723
  35. Sanders D, Bancroft J. Hormones and the sexuality of women—the menstrual cycle. Clin Endocrinol Metabol. 1982;11(3):639–659
  36. Bancroft J. Hormones, sexuality and fertility in women. J Zoology (London). 1987;213:445–454
  37. Bancroft J. Human sexuality and its problems. Edinburgh: Churchill Livingstone; 1989;
  38. Bancroft J. Commentary (biological contributions to sexual orientation). In:  McWhirter DP,  Sanders SA,  Reinisch JM editor. Homosexuality/heterosexuality. New York: Oxford University Press; 1990;p. 101–111
  39. Meyer-Bahlburg HFL. Commentary (what causes low rates of child-bearing in congenital adrenal hyperplasia?). J Clin Endocrinol Metabol. 1999;84:1844–1847
  40. Brincat M, Magos A, Studd JWW, Cardozo LD, O’Dowd T, Wardle PJ, et al.  Subcutaneous hormone implants for the control of climacteric symptoms. Lancet. 1984;16–18
  41. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987;49:397–409
  42. Davis SR, McCloud P, Strauss BJG, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas. 1995;21:227–236

PII: S0015-0282(02)02961-8

Fertility and Sterility
Volume 77 , Pages 55-59 , April 2002

Article Tools